From 1 January 2024, the EC Decision Reliance Procedure (ECDRP) has been replaced by the new International Recognition procedure (IRP). The Mutual Recognition/ Decentralised Reliance Procedure (MRDCRP) has been incorporated under the umbrella of IRP.
IRP will allow the MHRA to take into account the expertise and decision-making of trusted regulatory partners for the benefit of UK patients. The MHRA will conduct a targeted assessment of IRP applications but retain the authority to reject applications if the evidence provided is considered insufficiently robust.
For more details, go through this presentation.